OptimizeRx Corporation Common Stock (OPRX) Stock
NASDAQ · OPRX
7.29
Fundamentals
Market cap
$137.31M
Price / Earnings ratio
31.1x
Price / Sales ratio
1.4x
Price / Book ratio
1.1x
Return on assets
0.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About OptimizeRx Corporation Common Stock
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
SectorHealthcare
IndustryHealth Information Services
Employees132
CEOMr. Stephen L. Silvestro
IPO DateOct 22, 1996
HeadquartersWaltham, MA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Stephen L. Silvestro | CEO & Director | 1978 |
| Mr. Edward Stelmakh C.M.A., M.B.A. | Chief Financial & Strategic Officer | 1966 |
| Ms. Theresa Greco | Advisor | 1973 |
| Mr. Brendan Merrell | Chief Operating Officer | 1985 |
| Ms. Marion K Odence-Ford | Chief Legal & Administrative Officer | 1965 |
| Ms. Maira Alejandra | Media Relations Manager | — |
| Ms. Sarah Bast | Chief Marketing Officer | — |
| Mr. Andrew Jacob D'Silva | Chief Business Officer | 1986 |
| Jennifer Dinkel | SVP of Marketing | — |
| Ms. Heather Favazza | Controller | — |
Fundamentals
Valuation
Market cap$137.31M
Price-to-sales ratio1.45
Price-to-book value1.09
Price-earnings ratio31.10
Return on Equity6.00%
Return on Sales0.14%
Return on Assets0.04%
PEG ratio1.61
Earnings Per Share
Earnings Per Share$0.24
Income Statement
Average volume143,353
EBITDA$19.06M
1 year high (52w)$22.25
1 year low (52w)$4.54
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



